Published in Science on October 01, 1993
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol (1998) 8.45
Human parvovirus B19. Clin Microbiol Rev (2002) 3.44
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol (2001) 3.11
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol (1997) 2.91
Viral cell recognition and entry. Protein Sci (1994) 1.93
Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 1.82
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 1.70
Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J Virol (2000) 1.61
Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol (1998) 1.61
The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 A resolution. Structure (1998) 1.48
Structure of adeno-associated virus type 4. J Virol (2005) 1.47
Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 1.45
The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol (2002) 1.42
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol (2007) 1.40
Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol (2008) 1.39
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol (1995) 1.32
The structure of human parvovirus B19. Proc Natl Acad Sci U S A (2004) 1.30
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol (1994) 1.30
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A (1996) 1.29
Coronary microvascular dysfunction: an update. Eur Heart J (2013) 1.28
Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. J Virol (1999) 1.27
Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol (2008) 1.26
Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol (2006) 1.18
Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol (2001) 1.17
Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17
Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest (2010) 1.14
Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J Virol (2002) 1.13
Advances in human B19 erythrovirus biology. J Virol (2010) 1.10
Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion (2011) 1.09
Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. J Virol (2006) 1.05
Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus. J Virol (2010) 1.04
Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice. J Virol (1999) 1.04
Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J Virol (1996) 1.01
Deletion of a gene encoding an amino acid transporter in the midgut membrane causes resistance to a Bombyx parvo-like virus. Proc Natl Acad Sci U S A (2008) 1.01
Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J Virol (2003) 1.01
Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19. J Virol (1998) 1.01
Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol (2010) 1.00
Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J Virol (2008) 1.00
Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα. PLoS Pathog (2011) 0.99
Glycosphingolipids as receptors for non-enveloped viruses. Viruses (2010) 0.98
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology (2008) 0.96
Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS One (2010) 0.94
New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections. J Clin Microbiol (2001) 0.93
Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem J (1996) 0.93
Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev (2013) 0.91
Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism. J Virol (2013) 0.91
Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1. J Virol (2006) 0.91
Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells. J Virol (2001) 0.91
Parvovirus glycan interactions. Curr Opin Virol (2014) 0.90
Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol (2012) 0.89
Pathways of cell infection by parvoviruses and adeno-associated viruses. J Virol (2004) 0.89
Parvovirus particles as platforms for protein presentation. Proc Natl Acad Sci U S A (1994) 0.88
Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes. J Virol (1998) 0.88
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions. PLoS One (2012) 0.87
Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i). J Virol (1995) 0.87
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy. J Clin Microbiol (2002) 0.87
Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens. J Clin Microbiol (1994) 0.87
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19. J Virol (2001) 0.87
Acute parvovirus b19 infection leading to severe aplastic anemia in a previously healthy adult female. Indian J Hematol Blood Transfus (2011) 0.86
Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J Clin Microbiol (2000) 0.86
Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. J Virol (2012) 0.86
Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. J Virol (2012) 0.86
Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconj J (2009) 0.85
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer (2008) 0.83
CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells. Blood (2010) 0.83
The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization. J Virol (2010) 0.83
Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy. Med Microbiol Immunol (2003) 0.83
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. J Virol (2014) 0.83
Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation. Biol Blood Marrow Transplant (2008) 0.83
Genetic and environmental factors in polymyalgia rheumatica. Ann Rheum Dis (1997) 0.83
Identification of a cell surface protein from Crandell feline kidney cells that specifically binds Aleutian mink disease parvovirus. J Virol (1999) 0.83
Acute cerebellar ataxia with human parvovirus B19 infection. Arch Dis Child (1999) 0.82
Characterization of the early steps of human parvovirus B19 infection. J Virol (2012) 0.81
Human genetic disorders of sphingolipid biosynthesis. J Inherit Metab Dis (2014) 0.81
Transient parvovirus-associated hypoplasia of multiple peripheral blood cell lines in children with chronic hemolytic anemia. Pediatr Blood Cancer (2008) 0.80
Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent. BMC Pediatr (2014) 0.80
Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol (2001) 0.80
Human B19 erythrovirus in vitro replication: what's new? J Virol (2008) 0.79
Acquired Pure Red Cell Aplasia caused by Parvovirus B19 Infection following a Renal Transplant. Sultan Qaboos Univ Med J (2011) 0.79
Simian parvoviruses: biology and implications for research. Comp Med (2008) 0.79
SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA. J Family Community Med (2009) 0.79
Structure of an enteric pathogen, bovine parvovirus. J Virol (2014) 0.79
Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol (2015) 0.78
Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture. J Virol (1995) 0.78
Prevalence of antibodies to human parvovirus b19 in saudi women of childbearing age in makkah. J Family Community Med (2007) 0.78
Pharmacological activation of guanine nucleotide exchange factors for the small GTPase Rap1 recruits high-affinity beta1 integrins as coreceptors for parvovirus B19: improved ex vivo gene transfer to human erythroid progenitor cells. Hum Gene Ther (2009) 0.78
A new parvovirus: similarities between monkeys and humans. J Clin Invest (1994) 0.78
Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture. Int J Med Sci (2010) 0.78
[Molecular mechanisms and consequences of cardiac viral infections]. Pathologe (2008) 0.77
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells. PLoS One (2016) 0.77
Profiling of glycan receptors for minute virus of mice in permissive cell lines towards understanding the mechanism of cell recognition. PLoS One (2014) 0.76
Fatal parvoviral myocarditis: a case report and review of literature. Diagn Pathol (2008) 0.76
Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking. Viruses (2014) 0.76
Human parvovirus B19 infection in a renal transplant recipient: a case report. BMC Res Notes (2013) 0.76
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 4.99
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med (1994) 4.86
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N Engl J Med (1982) 3.29
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med (1987) 2.93
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet (2000) 2.75
An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia (2000) 2.73
Characterization of the transforming gene of Fujinami sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.68
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell (2001) 2.44
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood (2000) 2.42
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med (1999) 2.17
Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest (1989) 2.08
Germinal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells. J Exp Med (2000) 2.03
Dorsal laminectomy in the treatment of cervical intervertebral disk disease in small dogs: a retrospective study of 30 cases. J Am Anim Hosp Assoc (1996) 1.98
Hepatitis-associated aplastic anemia. N Engl J Med (1997) 1.98
Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet (1988) 1.97
Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology (1996) 1.97
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci (2002) 1.94
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood (1995) 1.91
Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood (2001) 1.89
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med (1989) 1.85
Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci U S A (1992) 1.82
Characterization of a virus that causes transient aplastic crisis. J Clin Invest (1984) 1.78
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol (1993) 1.76
Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood (1994) 1.75
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74
Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood (1989) 1.69
Biochemical and molecular analysis of naturally occurring Adh variants in Drosophila melanogaster. Proc Natl Acad Sci U S A (1983) 1.69
Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med (1984) 1.66
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat Med (1995) 1.65
Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. J Biol Chem (1999) 1.65
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest (1992) 1.63
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis (1997) 1.63
Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus. J Virol (1983) 1.63
Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J Biol Chem (1999) 1.59
Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol (1996) 1.57
Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol (2001) 1.57
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol (1989) 1.56
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood (1996) 1.56
Correction of the PNH defect by GPI-anchored protein transfer. Blood (1998) 1.55
Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood (1997) 1.55
Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3. Br J Haematol (1991) 1.50
A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol (1992) 1.48
gag-Related polypeptides encoded by replication-defective avian oncoviruses. J Virol (1979) 1.48
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J Thromb Haemost (2012) 1.47
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood (1999) 1.47
Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med (1994) 1.45
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol (1993) 1.45
Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr (1998) 1.44
Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med (1985) 1.43
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood (1986) 1.42
p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol (1996) 1.40
Fanconi anemia and novel strategies for therapy. Blood (1994) 1.39
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39
The structure of human parvovirus B19 at 8 A resolution. Virology (1994) 1.38
Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol (1984) 1.38
Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand. Hepatology (1997) 1.38
Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol Cell Biol (2000) 1.35
Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus. Proc Natl Acad Sci U S A (1984) 1.34
Tryptic peptide analysis of avian oncovirus gag and pol gene products. J Virol (1979) 1.33
Biochemical differences between products of the Adh locus in Drosophila. Genetics (1980) 1.33
Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol (1995) 1.33
Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood (1996) 1.32
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol (1994) 1.30
The role of lysine 529, a conserved residue of the acyl-adenylate-forming enzyme superfamily, in firefly luciferase. Biochemistry (2000) 1.29
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A (1996) 1.29
Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol (1994) 1.28
Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci U S A (1994) 1.28
Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther (1999) 1.28
Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol (1995) 1.27
gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med (1994) 1.26
Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest (1994) 1.26
Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) (1992) 1.25
Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest (2001) 1.25
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood (2001) 1.24
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood (1996) 1.24
Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol (1985) 1.23
Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem (1999) 1.23
Infection of mononucleated phagocytes with human cytomegalovirus. Virology (1993) 1.23
A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A (1989) 1.22
First continuous propagation of B19 parvovirus in a cell line. Blood (1992) 1.22
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia (2011) 1.21
The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis (1986) 1.20
Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood (1998) 1.19
Src-related protein tyrosine kinases in hematopoiesis. Blood (1999) 1.19
Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol (1997) 1.17
The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci U S A (1996) 1.17